Abstract:
The present invention relates to Mycoplasma synoviae Korean isolates which are main pathogenic bacteria which cause infectious synovitis and respiratory symptoms in chickens and, more specifically, to M.synoviae MS-09-AR vaccine (deposit number : KCTC12342BP) among M.synoviae isolates having high contagiousness and immunogenicity which are isolated from domestic chickens.